Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report

medRxiv(2021)10.1101/2021.11.08.21266069Source: DataRank Database

De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

doi pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (34)IDs (PubMed, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Jon Klein ORCID,Alexander J. Robertson ORCID,Mario A. Peña-Hernández,Michelle J. Lin ORCID,Pavitra Roychoudhury ORCID

Live enrichment

PubMed:34909781 OpenAlex:https://openalex.org/W3213339583

National Institutes of Health

Grant: 2T32AI007517-21A1

Training in Investigative Infectious Diseases

NIAID NIH HHS

Grant: T32 AI007517

NCATS NIH HHS

Grant: UL1 TR001863

greenLicense: CC BY

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/12/07/2021.11.08.21266069.full.pdf

repositoryhttps://doi.org/10.1101/2021.11.08.21266069

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34909781

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8669848

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing0303 health sciences03 medical and health sciences

Keywords

MutationVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineIn vitroCoronavirus disease 2019 (COVID-19)ImmunologyDrug resistanceAntiviral treatmentViral sheddingBiologyVirusDiseaseGeneGeneticsInternal medicineInfectious disease (medical specialty)AlanineCoronavirus RNA-Dependent RNA PolymeraseSARS-CoV-2ScienceQAntibodies, Monoclonal, HumanizedArticleAdenosine MonophosphateCOVID-19 Drug TreatmentImmunocompromised HostHumansFemale

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report

FAIR Checklist

Authors (23)

Funding (3 grants)

Open Access

Topics

Annotations (Europe PMC)